Bioanalysis News and Research

RSS

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

Celerion, a privately owned contract research organization (CRO), has completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services. The acquired assets include five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and Belfast, Northern Ireland, as well as operations in Richmond, Virginia and Quebec, Canada.

29 Mar 2010

Mini-laboratory: IVD platform to be presented at Analytica trade show

Many illnesses can be reliably diagnosed through laboratory tests, but these in vitro analyses often use up valuable time. A system developed by Fraunhofer research scientists, which can carry out complex analyses on the spot, will soon be ready for the market.

19 Mar 2010

New bioanalytical methods have potential for investigative and screening applications

The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.

3 Feb 2010

Varian announces the release of significant additions to its family of Pursuit LC columns

Varian, Inc. announced today the release of significant additions to its family of Pursuit™ LC (liquid chromatography) columns for pharmaceutical applications. New materials address needs from drug discovery to bioanalysis, saving time on analysis and method development.

20 Jan 2010

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

Bioanalysis News and Research

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

Mini-laboratory: IVD platform to be presented at Analytica trade show

New bioanalytical methods have potential for investigative and screening applications

Varian announces the release of significant additions to its family of Pursuit LC columns

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

New nanostructured biosensors

Advances in vivo biological imaging

Researchers develop technique to concentrate, manipulate and separate a wide class of swimming bacteria

Digital magnetofluidics holds hope for better medicine

New service-oriented laboratory focused on bioanalysis and pharmacokinetics

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News